$ 482.41
Key Takeaways
Risk factor
Negligible price volatility
Profitability factor
Overvalued vs peers
About
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections...
Company Valuation
Based on key historical and expected multiples, the stock is overvalued relative to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITDA, over
Target Price
The average target price of TMO is 547 and suggests 13% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation su
